🔎 Trials Near Me

Home › Atrial Fibrillation › Oklahoma › Oklahoma City

Atrial Fibrillation clinical trials in Oklahoma City, OK

7 studies for Atrial Fibrillation are looking for participants at sites in and around Oklahoma City (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation

RecruitingPhase 3
  • University of Oklahoma Health Sciences Center, Oklahoma City
Ages 22 to 85 · All sexes · Updated Sep 30, 2026 · NCT05836987

A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation

Recruiting
  • Oklahoma Heart Hospital, Oklahoma City
Ages 18 to 80 · All sexes · Updated Sep 25, 2026 · NCT07527299

Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias

RecruitingObservational study
  • Oklahoma Heart Hospital, Oklahoma City
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT04088071

Detection of Atrial Fibrillation Using PPG From Smartphone Cameras

RecruitingObservational study
  • CardioVascular Health Clinic, Oklahoma City
22 Minutes · All sexes · Updated Aug 21, 2026 · NCT07779213

Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

RecruitingPhase 3
  • Anthos Investigative Site 9917, Oklahoma City
Ages 65 and older · All sexes · Updated Jul 13, 2026 · NCT05712200

Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

RecruitingPhase 3
  • OU Medical Center, Oklahoma City
  • Mercy Hospital Oklahoma City, Oklahoma City
Ages 18 and older · All sexes · Updated May 8, 2026 · NCT03907046

Dapagliflozin in Patients With Atrial Fibrillation (DAPA-AF)

RecruitingPhase 3
  • University of Oklahoma Health Sciences Center, Oklahoma City
Ages 18 to 85 · All sexes · Updated Apr 1, 2026 · NCT05174052

About Atrial Fibrillation

Atrial fibrillation (AF or AFib) is the most common type of arrhythmia (irregular heartbeat). Read about symptoms and treatment.

More about Atrial Fibrillation on MedlinePlus

Atrial Fibrillation trials in other cities

Other studies in Oklahoma City

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.